| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:prto | nasdaq:prto Shareholders | 13F-HR/A | 0000948046-21-000195 | Sep 30th, 2018 12:00AM | Dec 21st, 2021 12:00AM | Dec 21st, 2021 12:00AM | DEUTSCHE BANK AG\ | 948046 | PROTEON THERAPEUTICS INC | COM | 74371L109 | 84 | 42900 | SH | DFND | 42900 | 0 | 0 | May 5th, 2022 07:59AM | May 5th, 2022 07:59AM | Proteon Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:prto | nasdaq:prto Shareholders | 13F-HR | 0000950123-18-012094 | Sep 30th, 2018 12:00AM | Nov 15th, 2018 12:00AM | Nov 15th, 2018 12:00AM | Pharmstandard International S.A. | 1598762 | Proteon Therapeutics Inc. | Common | 74371L109 | 3135 | 1607807 | SH | DFND | 1 | 0 | 1607807 | 0 | Dec 8th, 2021 01:43PM | Dec 8th, 2021 01:43PM | Proteon Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:prto | nasdaq:prto Shareholders | 13F-HR | 0001567619-18-006280 | Sep 30th, 2018 12:00AM | Nov 14th, 2018 12:00AM | Nov 14th, 2018 12:00AM | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1009258 | PROTEON THERAPEUTICS INC | COM | 74371L109 | 2389 | 1224899 | SH | DFND | 01 | 1224899 | 0 | 0 | Dec 8th, 2021 01:29PM | Dec 8th, 2021 01:29PM | Proteon Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:prto | nasdaq:prto Shareholders | 13F-HR | 0001493152-18-015893 | Sep 30th, 2018 12:00AM | Nov 14th, 2018 12:00AM | Nov 14th, 2018 12:00AM | BOOTHBAY FUND MANAGEMENT, LLC | 1549230 | PROTEON THERAPEUTICS INC | COM | 74371L109 | 207 | 106241 | SH | SOLE | 106241 | 0 | 0 | Dec 8th, 2021 01:26PM | Dec 8th, 2021 01:26PM | Proteon Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:prto | nasdaq:prto Shareholders | 13F-HR | 0001481986-18-000006 | Sep 30th, 2018 12:00AM | Nov 14th, 2018 12:00AM | Nov 14th, 2018 12:00AM | DRW Securities, LLC | 1481986 | PROTEON THERAPEUTICS INC | COM | 74371L109 | 48 | 24867 | SH | OTR | 1 | 0 | 0 | 0 | Dec 8th, 2021 01:26PM | Dec 8th, 2021 01:26PM | Proteon Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:prto | nasdaq:prto Shareholders | 13F-HR | 0001144204-18-059977 | Sep 30th, 2018 12:00AM | Nov 14th, 2018 12:00AM | Nov 14th, 2018 12:00AM | RA CAPITAL MANAGEMENT, LLC | 1346824 | PROTEON THERAPEUTICS INC | COM | 74371L109 | 2608 | 1337462 | SH | SOLE | 1337462 | 0 | 0 | Dec 8th, 2021 01:21PM | Dec 8th, 2021 01:21PM | Proteon Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:prto | nasdaq:prto Shareholders | 13F-HR | 0001144204-18-059891 | Sep 30th, 2018 12:00AM | Nov 14th, 2018 12:00AM | Nov 14th, 2018 12:00AM | BAKER BROS. ADVISORS LP | 1263508 | Proteon Therapeutics, Inc. | COM | 74371L109 | 582 | 298591 | SH | SOLE | 298591 | 0 | 0 | Dec 8th, 2021 01:21PM | Dec 8th, 2021 01:21PM | Proteon Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:prto | nasdaq:prto Shareholders | 13F-HR | 0001012975-18-001239 | Sep 30th, 2018 12:00AM | Nov 14th, 2018 12:00AM | Nov 14th, 2018 12:00AM | PERCEPTIVE ADVISORS LLC | 1224962 | PROTEON THERAPEUTICS INC | COM | 74371L109 | 469 | 240488 | SH | SOLE | 240488 | 0 | 0 | Dec 8th, 2021 01:16PM | Dec 8th, 2021 01:16PM | Proteon Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:prto | nasdaq:prto Shareholders | 13F-HR | 0000950123-18-011989 | Sep 30th, 2018 12:00AM | Nov 14th, 2018 12:00AM | Nov 14th, 2018 12:00AM | Deer VII & Co. Ltd. | 1540726 | PROTEON THERAPEUTICS INC | COM | 74371L109 | 614 | 315101 | SH | DFND | 1 | 315101 | 0 | 0 | Dec 8th, 2021 01:16PM | Dec 8th, 2021 01:16PM | Proteon Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:prto | nasdaq:prto Shareholders | 13F-HR | 0000950123-18-011743 | Sep 30th, 2018 12:00AM | Nov 14th, 2018 12:00AM | Nov 14th, 2018 12:00AM | MPM ASSET MANAGEMENT LLC | 1263048 | Proteon Therapeutics, Inc. | Common | 74371L109 | 1918 | 983381 | SH | SOLE | 983381 | 0 | 0 | Dec 8th, 2021 01:15PM | Dec 8th, 2021 01:15PM | Proteon Therapeutics | Health Care | Pharmaceuticals & Biotechnology |